Cargando…
Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase
Glycycoumarin (GCM) is a major bioactive coumarin compound isolated from licorice and the anti-cancer activity of GCM has not been scientifically addressed. In the present study, we have tested the anti-liver cancer activity of GCM using both in vitro and in vivo models and found for the first time...
Autores principales: | Song, Xinhua, Yin, Shutao, Zhang, Enxiang, Fan, Lihong, Ye, Min, Zhang, Yong, Hu, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323188/ https://www.ncbi.nlm.nih.gov/pubmed/27582549 http://dx.doi.org/10.18632/oncotarget.11610 |
Ejemplares similares
-
Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway
por: Zhang, Enxiang, et al.
Publicado: (2016) -
Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis
por: Zhang, Enxiang, et al.
Publicado: (2018) -
Pharmacological Activities and Pharmacokinetics of Glycycoumarin
por: Tang, Yumei, et al.
Publicado: (2022) -
p53 activation contributes to patulin-induced nephrotoxicity via modulation of reactive oxygen species generation
por: Jin, Huan, et al.
Publicado: (2016) -
Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase
por: Fan, Xiaoming, et al.
Publicado: (2019)